HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeremiah Hadwen Selected Research

Jeremiah Hadwen Research Topics

Disease

3Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2014 - 08/2011
2Rare Diseases (Rare Disease)
06/2021 - 03/2019
1Arteriovenous Fistula
03/2023
1Transverse Myelitis (Necrotizing Myelitis)
04/2022
1Spinal Cord Diseases
04/2022
1Infarction (Infarctions)
04/2022
1Fistula
04/2022
1Muscular Dystrophies (Muscular Dystrophy)
06/2021
1Stroke (Strokes)
01/2021
1Insulin Resistance
01/2021
1Peripheral Nervous System Diseases (PNS Diseases)
01/2018
1Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1Respiratory Insufficiency (Respiratory Failure)
01/2018
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2018
1Myotonic Dystrophy (Dystrophia Myotonica)
08/2015
1Infant Death
01/2014
1Muscular Atrophy (Muscle Atrophy)
09/2013

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
03/2019 - 09/2013
1SteroidsIBA
04/2022
1DNA (Deoxyribonucleic Acid)IBA
06/2021
1RNA (Ribonucleic Acid)IBA
06/2021
1Insulin (Novolin)FDA Link
01/2021
1Messenger RNA (mRNA)IBA
03/2019
1UtrophinIBA
01/2018
1AnisomycinIBA
01/2018
1Thyroid HormonesIBA
01/2018
1DystrophinIBA
01/2018
1Protein Kinases (Protein Kinase)IBA
08/2015
13' Untranslated Regions (3' UTR)IBA
08/2015
1Type II Vasoactive Intestinal Peptide ReceptorsIBA
01/2014
1Lys(15)-Arg(16)-Leu(27)- vasoactive intestinal peptide (1-7)-GRF (8-27)IBA
01/2014
1Celecoxib (Celebrex)FDA Link
09/2013
1ProlactinIBA
08/2011

Therapy/Procedure

1Punctures
03/2023
1Therapeutics
03/2019